Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Advanced Diffusion Imaging in Renal Cancer Patients

NCT: NCT06116253 · ACTIVE_NOT_RECRUITING

NCT IDNCT06116253
StatusACTIVE_NOT_RECRUITING
Start Date2022-12-01
Completion2028-12-01

Brief Summary

The objective of this study is to apply advanced diffusion imaging in a two-pronged assessment of renal mass patients: (1) characterization of lesion malignancy and subtype, and (2) prediction of renal function stability or decline following partial nephrectomy.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑